Picture of GH Research logo

GHRS GH Research Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for GH Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-9.2-22.5-35.6-39-48.3
Depreciation
Non-Cash Items-5.53-5.950.291-3.837.46
Other Non-Cash Items
Changes in Working Capital-0.5682.161.650.188-3.09
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-15.3-26.2-33.3-42.3-43.6
Capital Expenditures-0.104-0.067-0.1-0.049-0.121
Purchase of Fixed Assets
Other Investing Cash Flow Items-84.6-5465.246.3
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.104-84.7-54.165.146.2
Financing Cash Flow Items-22.800-10.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2860-0.204-0.304140
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash271-111-87.522.4145